Michael Herrler

IPM provides disciplined on-site leadership to execute projects in the area of product and technology development, portfolio and resource planning, lifecycle management, technology and manufacturing transfer, regulatory submission and compliance, launch readiness and commercialization, supply chain and manufacturing optimization, M&A due diligence and integration, quality assurance, business process improvement, capital planning and build-out, geographic expansion, PMO creation and enhancement.

Start-Up Advice: • Perform market opportunity analysis, help to build the right team, guide fund-raising activities • Provide expertise in project management and new product development; B2B Services: • Assist foreign companies in defining market entry strategies into the U.S.; Teaching: • New Product Development. Board Member of the NPDP Certification Committee at the Product Development & Management Association (PDMA)

Targeting three markets with major growth in 2011: • Social Business • Smarter Commerce • Business Analytics. More info coming soon!

• Developed and teach a course entitled "Medical Devices-Development & Regulation" as part of the University's "Clinical Trials Design & Management" certificate program • The next class is scheduled for Spring 2011 (http://www.cel.sfsu.edu/brochures/fall10/biotechnology.pdf)

• Member of the Sr. Management Team, reported directly to the CEO • Directed the company's platform development program and managed the commercialization of all consumable products • Participated in business development activities with premier diagnostic & life sciences companies • Turnaround manager, involved in capital-raising activities and analysis of strategic options for the company

• Member of the Executive Team • Responsible for product strategy development • Managed strategic alliances & collaborations with KOLs in the U.S. and Europe • Directed the company’s oncology diagnostics development program • Involved in "bridge" funding and M&A activities • Influenced and impacted the successful business turnaround for the parent company Applied Imaging that lead to an acquisition

• Reported directly to NuGEN’s General Manager • Guided the company’s stage-gate based “New Product Development & Commercialization Process” • Directed a cross-functional project team and provided tactical guidance to the development team • Actively contributed to product strategy formulation and implementation • Launched the company's first product on time and within budget

• Reported to Clontech’s VP of R&D and supervised a staff of nine, including three Ph.D. scientists • Defined market opportunities for new products/services and initiated, directed and executed comprehensive strategies in the field of genomics that led to the successful launch of >30 products • Managed the company's Premium RNA products that accounted for approximately 20% of company’s total product sales in 2002 • Actively participated in interdepartmental collaborations & business development activities

• Conducted research on chromatin regulation • Selected publication: Herrler et al. (1998). EMBO J. 17, 6300-6315.

• Research on antibiotic synthetases • Constructed cosmid DNA libraries and developed PCR-based screening strategies

Euro*MBA's candidate for the MBA Student of the Year Award 2009 Partnering institutions: • AUDENCIA Nantes (France) • EADA Barcelona (Spain) • IAE Aix-en-Provence (France) • LKAEM Warsaw (Poland) • UMBS (The Netherlands) • HHL Leipzig (Germany)

• Thesis (with distinction) • Publications in Nature, Nature Structural Biology, Biochemistry